Meiji Yasuda Asset Management CO Ltd. Eli Lilly & CO Transaction History

Meiji Yasuda Asset Management CO Ltd.

  • $2.57 Billion
  • Q3 2024

A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 27,037 shares of LLY stock, worth $21.5 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
27,037
Previous 26,527 1.92%
Holding current value
$21.5 Million
Previous $24 Million 0.27%
% of portfolio
0.93%
Previous 0.99%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$772.14 - $960.02 $393,791 - $489,610
510 Added 1.92%
27,037 $24 Million
Q2 2024

Aug 12, 2024
BUY
$724.87 - $909.04 $1.03 Million - $1.3 Million
1,427 Added 5.69%
26,527 $24 Million
Q1 2024

May 15, 2024
BUY
$592.2 - $792.28 $507,515 - $678,983
857 Added 3.54%
25,100 $19.5 Million
Q4 2023

Feb 14, 2024
SELL
$525.19 - $619.13 $398,619 - $469,919
-759 Reduced 3.04%
24,243 $14.1 Million
Q3 2023

Nov 13, 2023
BUY
$434.7 - $599.3 $4.88 Million - $6.72 Million
11,217 Added 81.37%
25,002 $13.4 Million
Q2 2023

Aug 14, 2023
SELL
$350.74 - $468.98 $150,116 - $200,723
-428 Reduced 3.01%
13,785 $6.47 Million
Q1 2023

May 09, 2023
SELL
$310.63 - $364.82 $2.09 Million - $2.46 Million
-6,733 Reduced 32.14%
14,213 $4.88 Million
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $137,301 - $159,984
-427 Reduced 2.0%
20,946 $7.66 Million
Q3 2022

Nov 14, 2022
SELL
$296.48 - $337.87 $178,777 - $203,735
-603 Reduced 2.74%
21,373 $6.91 Million
Q2 2022

Aug 16, 2022
SELL
$278.73 - $327.27 $3.48 Million - $4.09 Million
-12,494 Reduced 36.25%
21,976 $7.13 Million
Q1 2022

May 17, 2022
SELL
$234.69 - $291.66 $369,871 - $459,656
-1,576 Reduced 4.37%
34,470 $9.87 Million
Q4 2021

Feb 14, 2022
SELL
$224.85 - $279.04 $2.11 Million - $2.62 Million
-9,387 Reduced 20.66%
36,046 $9.96 Million
Q3 2021

Nov 12, 2021
SELL
$221.6 - $272.71 $291,625 - $358,886
-1,316 Reduced 2.82%
45,433 $10.5 Million
Q2 2021

Aug 13, 2021
SELL
$180.55 - $233.54 $376,627 - $487,164
-2,086 Reduced 4.27%
46,749 $10.7 Million
Q1 2021

May 14, 2021
BUY
$164.32 - $212.72 $2.54 Million - $3.29 Million
15,488 Added 46.44%
48,835 $9.12 Million
Q4 2020

Feb 12, 2021
BUY
$130.46 - $172.63 $583,156 - $771,656
4,470 Added 15.48%
33,347 $5.63 Million
Q3 2020

Nov 12, 2020
SELL
$146.22 - $169.13 $995,758 - $1.15 Million
-6,810 Reduced 19.08%
28,877 $4.27 Million
Q2 2020

Aug 13, 2020
BUY
$136.42 - $164.18 $3.04 Million - $3.66 Million
22,270 Added 165.98%
35,687 $5.86 Million
Q1 2020

May 14, 2020
SELL
$119.05 - $147.35 $3.47 Million - $4.29 Million
-29,125 Reduced 68.46%
13,417 $1.86 Million
Q4 2019

Feb 13, 2020
BUY
$106.92 - $132.43 $552,776 - $684,663
5,170 Added 13.83%
42,542 $5.59 Million
Q3 2019

Nov 13, 2019
BUY
$106.79 - $116.16 $22,425 - $24,393
210 Added 0.57%
37,372 $4.18 Million
Q2 2019

Aug 13, 2019
SELL
$110.79 - $129.32 $843,111 - $984,125
-7,610 Reduced 17.0%
37,162 $4.12 Million
Q1 2019

May 14, 2019
SELL
$111.31 - $131.02 $266,364 - $313,530
-2,393 Reduced 5.07%
44,772 $5.81 Million
Q4 2018

Feb 12, 2019
SELL
$105.9 - $118.64 $1.04 Million - $1.17 Million
-9,857 Reduced 17.29%
47,165 $5.46 Million
Q3 2018

Nov 13, 2018
SELL
$85.86 - $107.31 $28,333 - $35,412
-330 Reduced 0.58%
57,022 $6.12 Million
Q2 2018

Aug 13, 2018
BUY
$75.7 - $86.88 $74,186 - $85,142
980 Added 1.74%
57,352 $4.89 Million
Q1 2018

May 14, 2018
BUY
$74.21 - $87.6 $168,456 - $198,852
2,270 Added 4.2%
56,372 $4.36 Million
Q4 2017

Feb 13, 2018
BUY
$81.94 - $87.89 $91,772 - $98,436
1,120 Added 2.11%
54,102 $4.57 Million
Q3 2017

Nov 08, 2017
BUY
$77.07 - $85.54 $4.08 Million - $4.53 Million
52,982
52,982 $4.53 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email